Latest reported quarter: Q2, ended Jun 2026
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $3.78M | $3.05M | $85.21M | $85.09M | $90,000.00 |
| Total Operating Revenue | $3.78M | $3.05M | $85.21M | $85.09M | $90,000.00 |
| Operating Expense | $80.81M | $76.67M | $244.76M | $70.38M | $61.28M |
| Selling and Admin Expenses | $12.52M | $11.69M | $49.06M | $12.77M | $11.84M |
| -General & Admin Expense | $12.52M | $11.69M | $49.06M | $12.77M | $11.84M |
| Research & Development | $68.28M | $64.98M | $195.70M | $57.61M | $49.44M |
| Operating Profit | -$77.03M | -$73.62M | -$159.55M | $14.72M | -$61.19M |
| Net Non-Operating Interest Income (Expense) | $4.26M | $4.86M | $19.48M | $4.70M | $4.33M |
| Non-Operating Interest Income | $4.26M | $4.86M | $19.48M | $4.70M | $4.33M |
| Other Income (Expense) | -$166,000.00 | -$4,000.00 | -$37,000.00 | -$22,000.00 | -$21,000.00 |
| Other Non-Operating Income (Expenses) | -$166,000.00 | -$4,000.00 | -$37,000.00 | -$22,000.00 | -$21,000.00 |
| Pretax Profit | -$72.94M | -$68.76M | -$140.11M | $19.40M | -$56.88M |
| Net Profit | -$72.94M | -$68.76M | -$140.11M | $19.40M | -$56.88M |
| Profit from Continuing Operations | -$72.94M | -$68.76M | -$140.11M | $19.40M | -$56.88M |
| Net Income to Parent Company | -$72.94M | -$68.76M | -$140.11M | $19.40M | -$56.88M |
| Net Income to Common Stockholders | -$72.94M | -$68.76M | -$140.11M | $19.40M | -$56.88M |
| Basic EPS | -$1.04 | -$1.01 | -$2.42 | $0.43 | -$1.01 |
| Diluted EPS | -$1.04 | -$1.01 | -$2.42 | $0.43 | -$1.01 |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $492.62M | $512.91M | $566.71M | $566.71M | $423.98M |
| Total Current Assets | $382.96M | $405.36M | $413.13M | $413.13M | $312.38M |
| Cash and Cash Equivalents & Short-Term Investments | $361.33M | $390.89M | $402.66M | $402.66M | $305.06M |
| -Cash and Cash Equivalents | $70.37M | $72.49M | $60.24M | $60.24M | $48.56M |
| -Short Term Investments | $290.96M | $318.40M | $342.41M | $342.41M | $256.51M |
| Receivables | $4.61M | – | – | – | – |
| -Other Receivables | $4.61M | – | – | – | – |
| Other Current Assets | $17.01M | $14.47M | $10.48M | $10.48M | $7.31M |
| Total Non-Current Assets | $109.66M | $107.54M | $153.58M | $153.58M | $111.61M |
| Net PPE | $28.93M | $30.94M | $33.01M | $33.01M | $35.06M |
| -Gross PPE | $52.37M | $53.49M | $54.29M | $54.29M | $55.12M |
| -Accumulated Depreciation | -$23.44M | -$22.55M | -$21.28M | -$21.28M | -$20.06M |
| Investments and Advances | $69.30M | $66.74M | $111.38M | $111.38M | $67.17M |
| -Available for Sale Securities | $69.30M | $66.74M | $111.38M | $111.38M | $67.17M |
| Other Non-Current Assets | $11.44M | $9.86M | $9.19M | $9.19M | $9.38M |
| Total Liabilities | $84.96M | $61.07M | $61.05M | $61.05M | $55.00M |
| Total Current Liabilities | $47.67M | $43.40M | $43.99M | $43.99M | $37.11M |
| Payables | $12.52M | $14.69M | $11.16M | $11.16M | $6.86M |
| -Accounts Payable | $12.52M | $14.69M | $11.16M | $11.16M | $6.86M |
| Current Accrued Expenses | $25.43M | $22.87M | $26.87M | $26.87M | $24.19M |
| Short-Term Debt and Capital Lease Obligation | $5.37M | $5.49M | $5.59M | $5.59M | $5.70M |
| -Current Capital Lease Obligation | $5.37M | $5.49M | $5.59M | $5.59M | $5.70M |
| Current Deferred Liabilities | $4.35M | $360,000.00 | $360,000.00 | $360,000.00 | $360,000.00 |
| Total Non-Current Liabilities | $37.28M | $17.67M | $17.06M | $17.06M | $17.89M |
| Long Term Debt and Capital Lease Obligation | $33.84M | $15.05M | $15.82M | $15.82M | $16.57M |
| -Long Term Debt | $19.59M | – | – | – | – |
| -Long Term Capital Lease Obligation | $14.26M | $15.05M | $15.82M | $15.82M | $16.57M |
| Derivative Product Liabilities | $384,000.00 | $370,000.00 | $358,000.00 | $358,000.00 | $345,000.00 |
| Non-Current Deferred Liabilities | $2.96M | $2.13M | $745,000.00 | $745,000.00 | $835,000.00 |
| Other Non-Current Liabilities | $101,000.00 | $121,000.00 | $138,000.00 | $138,000.00 | $144,000.00 |
| Total Equity | $407.66M | $451.84M | $505.66M | $505.66M | $368.98M |
| Stockholders' Equity | $407.66M | $451.84M | $505.66M | $505.66M | $368.98M |
| Capital Stock | $6,000.00 | $5,000.00 | $6,000.00 | $6,000.00 | $5,000.00 |
| -Common Stock | $6,000.00 | $5,000.00 | $6,000.00 | $6,000.00 | $5,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $1.27B | $1.24B | $1.22B | $1.22B | $1.10B |
| Retained Earnings | -$858.00M | -$785.06M | -$716.30M | -$716.30M | -$735.70M |
| Gains/Losses Not Affecting Retained Earnings | -$446,000.00 | -$180,000.00 | $727,000.00 | $727,000.00 | $671,000.00 |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$70.00M | -$68.13M | -$109.08M | $28.55M | -$46.50M |
| Net cash flow from continuing operations | -$70.00M | -$68.13M | -$109.08M | $28.55M | -$46.50M |
| Net Income from Continuing Operations | -$72.94M | -$68.76M | -$140.11M | $19.40M | -$56.88M |
| Gain/Loss from Continuing Operations | $57,000.00 | $12,000.00 | -$52,000.00 | $13,000.00 | $11,000.00 |
| Depreciation & Depletion & Amortization | $2.09M | $2.06M | $7.63M | $1.98M | $2.00M |
| Change in Working Capital | -$4.10M | -$4.75M | $6.17M | $2.76M | $5.00M |
| -Change in Prepaid Assets | -$6.53M | -$3.99M | -$424,000.00 | -$3.17M | $2.75M |
| -Change in Payables and Accrued Expense | $2.49M | -$590,000.00 | $14.93M | $6.67M | $3.15M |
| -Change in Other Current Assets | $18,000.00 | -$670,000.00 | -$4.93M | $192,000.00 | $10,000.00 |
| -Change in Other Current Liabilities | -$905,000.00 | -$878,000.00 | -$3.19M | -$850,000.00 | -$814,000.00 |
| -Change In Other Working Capital | $830,000.00 | $1.38M | -$209,000.00 | -$90,000.00 | -$90,000.00 |
| Net cash flow from investing | $25.54M | $68.89M | -$92.97M | -$128.85M | $17.78M |
| Net Cash Flow from Continuing Investing Activities | $25.54M | $68.89M | -$92.97M | -$128.85M | $17.78M |
| Net PPE Purchase and Sale | -$66,000.00 | $11,000.00 | -$536,000.00 | $70,000.00 | $91,000.00 |
| Net Investment Purchase and Sale | $25.61M | $68.88M | -$92.44M | -$128.92M | $17.69M |
| Financing Cash Flow | $42.34M | $11.48M | $112.96M | $111.98M | $116,000.00 |
| Net Cash Flow from Continuing Financing Activities | $42.34M | $11.48M | $112.96M | $111.98M | $116,000.00 |
| Net Common Stock Issuance | $21.84M | $9.81M | $110.72M | $110.72M | $0.00 |
| Proceeds from Stock Option Exercised | $1.24M | $1.67M | $2.24M | $1.26M | $116,000.00 |
| Ending Cash Balance | $70.37M | $72.49M | $60.24M | $60.24M | $48.56M |
| Net Change in Cash | -$2.12M | $12.25M | -$89.10M | $11.69M | -$28.60M |
| Beginning Cash Balance | $72.49M | $60.24M | $149.34M | $48.56M | $77.16M |
| Free Cash Flow | -$70.05M | -$68.13M | -$109.62M | $28.62M | -$46.41M |
No comments yet — be the first to weigh in on FDMT.